Patents by Inventor Ravinder Nath Maini

Ravinder Nath Maini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR TREATING RHEUMATOID ARTHRITIS WITH A HUMAN IL-6 RECEPTOR ANTIBODY AND METHOTREXATE
    Publication number: 20210283250
    Abstract: A pharmaceutical composition for the treatment of interleukin-6 (IL-6) related diseases, comprising an interleukin-6 antagonist (IL-6 antagonist) and immunosuppressants. The IL-6 antagonist is preferably an antibody to an interleukin-6 receptor (IL-6R).
    Type: Application
    Filed: May 28, 2021
    Publication date: September 16, 2021
    Applicant: Chugai Seiyaku Kabushiki Kaisha
    Inventors: Osamu OKUDA, Noriaki YOSHIDA, Ravinder Nath MAINI
  • METHOD FOR TREATING RHEUMATOID ARTHRITIS WITH A HUMAN IL-6 RECEPTOR ANTIBODY AND METHOTREXATE
    Publication number: 20210170024
    Abstract: A pharmaceutical composition for the treatment of interleukin-6 (IL-6) related diseases, comprising an interleukin-6 antagonist (IL-6 antagonist) and immunosuppressants. The IL-6 antagonist is preferably an antibody to an interleukin-6 receptor (IL-6R).
    Type: Application
    Filed: July 27, 2020
    Publication date: June 10, 2021
    Applicant: Chugai Seiyaku Kabushiki Kaisha
    Inventors: Osamu OKUDA, Noriaki YOSHIDA, Ravinder Nath MAINI
  • Method for treating rheumatoid arthritis with a human IL-6 receptor antibody and methotrexate
    Patent number: 10744201
    Abstract: A pharmaceutical composition for the treatment of interleukin-6 (IL-6) related diseases, comprising an interleukin-6 antagonist (IL-6 antagonist) and immunosuppressants. The IL-6 antagonist is preferably an antibody to an interleukin-6 receptor (IL-6R).
    Type: Grant
    Filed: March 13, 2018
    Date of Patent: August 18, 2020
    Assignee: Chugai Seiyaku Kabushiki Kaisha
    Inventors: Osamu Okuda, Noriaki Yoshida, Ravinder Nath Maini
  • METHOD FOR TREATING RHEUMATOID ARTHRITIS WITH A HUMAN IL-6 RECEPTOR ANTIBODY AND METHOTREXATE
    Publication number: 20190054167
    Abstract: A pharmaceutical composition for the treatment of interleukin-6 (IL-6) related diseases, comprising an interleukin-6 antagonist (IL-6 antagonist) and immunosuppressants. The IL-6 antagonist is preferably an antibody to an interleukin-6 receptor (IL-6R).
    Type: Application
    Filed: March 13, 2018
    Publication date: February 21, 2019
    Applicant: Chugai Seiyaku Kabushiki Kaisha
    Inventors: Osamu Okuda, Noriaki Yoshida, Ravinder Nath Maini
  • METHODS FOR TREATING INTERLEUKIN-6 RELATED DISEASES
    Publication number: 20150010554
    Abstract: A pharmaceutical composition for the treatment of interleukin-6 (IL-6) related diseases, comprising an interleukin-6 antagonist (IL-6 antagonist) and immunosuppressants. The IL-6 antagonist is preferably an antibody to an interleukin-6 receptor (IL-6R).
    Type: Application
    Filed: September 24, 2014
    Publication date: January 8, 2015
    Applicant: Chugai Seiyaku Kabushiki Kaisha
    Inventors: Osamu OKUDA, Noriaki YOSHIDA, Ravinder Nath MAINI
  • METHODS FOR TREATING INTERLEUKIN-6 RELATED DISEASES
    Publication number: 20140017236
    Abstract: A pharmaceutical composition for the treatment of interleukin-6 (IL-6) related diseases, comprising an interleukin-6 antagonist (IL-6 antagonist) and immunosuppressants. The IL-6 antagonist is preferably an antibody to an interleukin-6 receptor (IL-6R).
    Type: Application
    Filed: September 13, 2013
    Publication date: January 16, 2014
    Applicant: Chugai Seiyaku Kabushiki Kaisha
    Inventors: Osamu OKUDA, Noriaki YOSHIDA, Ravinder Nath Maini
  • TNF-alpha ANTAGONISTS AND METHOTREXATE IN THE TREATMENT OF TNF-MEDIATED DISEASE
    Publication number: 20130064816
    Abstract: Methods for treating and/or preventing a TNF-mediated disease in an individual are disclosed. Also disclosed is a composition comprising methotrexate and an anti-tumor necrosis factor antibody. TNF-mediated diseases include rheumatoid arthritis, Crohn's disease, and acute and chronic immune diseases associated with transplantation.
    Type: Application
    Filed: October 4, 2012
    Publication date: March 14, 2013
    Inventors: Marc Feldmann, Ravinder Nath Maini
  • Methods of treating rheumatoid arthritis with p75 TNF-alpha receptor and methotrexate
    Patent number: 7838489
    Abstract: Methods for treating and/or preventing a TNF-mediated disease in an individual are disclosed. Also disclosed is a composition comprising methotrexate and an anti-tumor necrosis factor antibody. TNF-mediated diseases include rheumatoid arthritis, Crohn's disease, and acute and chronic immune diseases associated with transplantation.
    Type: Grant
    Filed: October 7, 2008
    Date of Patent: November 23, 2010
    Assignee: The Mathilda and Terence Kennedy Institute of Rheumatology Trust
    Inventors: Marc Feldmann, Ravinder Nath Maini
  • TNFalpha antagonists and methotrexate in the treatment of TNF-mediated disease
    Publication number: 20090175859
    Abstract: Methods for treating and/or preventing a TNF-mediated disease in an individual are disclosed. Also disclosed is a composition comprising methotrexate and an anti-tumor necrosis factor antibody. TNF-mediated diseases include rheumatoid arthritis, Crohn's disease, and acute and chronic immune diseases associated with transplantation.
    Type: Application
    Filed: October 7, 2008
    Publication date: July 9, 2009
    Inventors: Marc Feldmann, Ravinder Nath Maini
  • Methods for treating interleukin-6 related diseases
    Patent number: 7521052
    Abstract: A pharmaceutical composition for the treatment of interleukin-6 (IL-6) related diseases, comprising an interleukin-6 antagonist (IL-6 antagonist) and immunosuppressants. The IL-6 antagonist is preferably an antibody to an interleukin-6 receptor (IL-6R).
    Type: Grant
    Filed: April 28, 2004
    Date of Patent: April 21, 2009
    Assignee: Chugai Seiyaku Kabushiki Kaisha
    Inventors: Osamu Okuda, Noriaki Yoshida, Ravinder Nath Maini
  • Multiple administrations of anti-TNF antibody
    Publication number: 20030064070
    Abstract: The invention relates to a method of treating an individual having a TNF-mediated disease comprising administering to the individual multiple doses of an anti-TNF antibody wherein the second or subsequent dose is administered during or immediately prior to relapse of the disease. Preferably, the disease is a TNF&agr;-mediated disease, such as rheumatoid arthritis. The anti-TNF antibody can be a monoclonal antibody or fragment thereof, such as a murine antibody, chimeric antibody or a humanized antibody or fragment thereof. Preferably, the antibody binds to one or more amino acids of human TNF&agr;(hTNF&agr;) selected from the group consisting of 87-108 and 59-80. The antibody can bind to the epitope of A2 or cA2. In a preferred embodiment, the antibody is A2 or cA2.
    Type: Application
    Filed: September 23, 2002
    Publication date: April 3, 2003
    Applicant: Centocor, Inc.
    Inventors: Marc Feldmann, Ravinder Nath Maini, James N. Woody